Core Laboratories Inc. /DE/
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $526.5 | $523.8 | $509.8 | $489.7 | $470.3 |
| Operating income | $56.5 | $58.6 | $54.6 | $41.5 | $45.3 |
| Net income | $29.7 | $31.4 | $36.7 | $19.5 | $19.7 |
| Cash Flow Statement | |||||
| Free cash flow | $25.8 | $44.5 | $14.2 | $14.7 | $23.0 |
| Dividends | $1.9 | $1.9 | $1.9 | $1.9 | $1.8 |
| Share repurchases | $12.4 | $5.3 | $2.2 | $3.9 | $8.3 |
Shares outstanding 45.9M · Free float 68.2%
Annual filing data through FY ended December 31, 2025; float as of October 6, 2026.